tirzepatide direct to consumer New Access and Pricing Through Self-Pay Options UPDATE [March 7, 2025]: OFA

No, it is not safe to do it yourself

Munib reviews your goals and recommends a cadence at consultation

Weekly injection, with oral forms emerging

The symptoms of gastroparesis may include feeling full shortly after starting a meal, feeling full long after eating a meal, nausea, and vomiting

February 23, 2026: New Weight Loss Drug Fails to Outperform Zepbound in Clinical Trial Zepbound was not outperformed in a clinical trial of a competitors new GLP-1 weight loss drug formulation

Unknown long-term profile: While short- and mid-term studies show good tolerability, the long-term safety of chronic Cagrilintide use is still being evaluated in Phase III trials